DMPHF
Price:
$39.56
Market Cap:
$1.84B
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Al...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-11-29
Stock Exchange
OTC
Ticker
DMPHF
According to Dermapharm Holding SE’s latest financial reports and current stock price. The company's current ROE is 17.42%. This represents a change of 302.67% compared to the average of 4.33% of the last 4 quarters.
The mean historical ROE of Dermapharm Holding SE over the last ten years is 34.80%. The current 17.42% ROE has changed -49.94% with respect to the historical average. Over the past ten years (40 quarters), DMPHF's ROE was at its highest in in the December 2017 quarter at 83.21%. The ROE was at its lowest in in the June 2023 quarter at -1.76%.
Average
34.80%
Median
28.63%
Minimum
11.57%
Maximum
105.51%
Discovering the peaks and valleys of Dermapharm Holding SE ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 256.93%
Maximum Annual ROE = 105.51%
Minimum Annual Increase = -14423.96%
Minimum Annual ROE = 11.57%
Year | ROE | Change |
---|---|---|
2024 | 18.83% | 62.76% |
2023 | 11.57% | -54.19% |
2022 | 25.25% | -40.08% |
2021 | 42.14% | 58.09% |
2020 | 26.66% | -3.78% |
2019 | 27.70% | -7.15% |
2018 | 29.84% | -71.72% |
2017 | 105.51% | 256.93% |
2016 | 29.56% | -4.34% |
2015 | 30.90% | -14423.96% |
The current ROE of Dermapharm Holding SE (DMPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.55%
5-year avg
24.89%
10-year avg
34.80%
Dermapharm Holding SE’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dermapharm Holding SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dermapharm Holding SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Dermapharm Holding SE's ROE?
How is the ROE calculated for Dermapharm Holding SE (DMPHF)?
What is the highest ROE for Dermapharm Holding SE (DMPHF)?
What is the 3-year average ROE for Dermapharm Holding SE (DMPHF)?
What is the 5-year average ROE for Dermapharm Holding SE (DMPHF)?
How does the current ROE for Dermapharm Holding SE (DMPHF) compare to its historical average?